Aubrey de Grey (Photo by Sergei Bobylev\TASS via Getty Images)
August 13, 2021 10:24 AM EDT
People

As Aubrey de Grey in­ves­ti­ga­tion swirled, SENS CEO left foun­da­tion in Ju­ly — re­port

Max Gelman

Senior Editor

A new de­vel­op­ment in the sex­u­al ha­rass­ment al­le­ga­tions against promi­nent an­ti-ag­ing re­searcher Aubrey de Grey is shed­ding light on some of the rea­sons his two …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times